258 related articles for article (PubMed ID: 24236882)
1. Clearing the fog: patenting trends for the treatment of Alzheimer's disease.
Lloyd M; Mokdsi G; Spielthenner D
Pharm Pat Anal; 2012 Sep; 1(4):437-55. PubMed ID: 24236882
[TBL] [Abstract][Full Text] [Related]
2. Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations.
Xu J; Kong X; Qiu L; Geng X; Hu Y; Wang Y
Expert Opin Ther Pat; 2014 Jul; 24(7):791-800. PubMed ID: 24798577
[TBL] [Abstract][Full Text] [Related]
3. Herbal drug patenting in India: IP potential.
Sahoo N; Manchikanti P; Dey SH
J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011).
Probst G; Xu YZ
Expert Opin Ther Pat; 2012 May; 22(5):511-40. PubMed ID: 22512789
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012).
Belluti F; Rampa A; Gobbi S; Bisi A
Expert Opin Ther Pat; 2013 May; 23(5):581-96. PubMed ID: 23425062
[TBL] [Abstract][Full Text] [Related]
6. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
7. The recent pharmaceutical patent landscape for Alzheimer's disease: an interview with Sang Min Lim.
Lim SM
Pharm Pat Anal; 2019 Nov; 8(6):215-216. PubMed ID: 31713460
[No Abstract] [Full Text] [Related]
8. Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows.
Liu K; Lin HH; Pi R; Mak S; Han Y; Hu Y
Expert Opin Ther Pat; 2018 Apr; 28(4):341-350. PubMed ID: 29421930
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Brazilian biotechnology patent activity from 1975 to 2010.
Dias F; Delfim F; Drummond I; Carmo AO; Barroca TM; Horta CC; Kalapothakis E
Recent Pat DNA Gene Seq; 2012 Aug; 6(2):145-59. PubMed ID: 22670606
[TBL] [Abstract][Full Text] [Related]
10. Ontology-based content analysis of US patent applications from 2001-2010.
Weber L; Böhme T; Irmer M
Pharm Pat Anal; 2013 Jan; 2(1):39-54. PubMed ID: 24236969
[TBL] [Abstract][Full Text] [Related]
11. Patents on potential drugs to treat Alzheimer's disease: special emphasis on small peptides.
Sundaram P; Nambiar AK; Sundaram RK
Recent Pat CNS Drug Discov; 2014; 9(2):71-5. PubMed ID: 25244580
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approaches of leptin in Alzheimer's disease.
Carro EM
Recent Pat CNS Drug Discov; 2009 Nov; 4(3):200-8. PubMed ID: 19891599
[TBL] [Abstract][Full Text] [Related]
13. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
Aymé S; Matthijs G; Soini S;
Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
[TBL] [Abstract][Full Text] [Related]
14. Patents in Nanobiotechnology: A Cross Jurisdictional Approach.
Manchikanti P; Uppala S; Bonta RK
Recent Pat Biotechnol; 2017; 11(1):52-70. PubMed ID: 27881055
[TBL] [Abstract][Full Text] [Related]
15. Building structure-activity insights through patent mining.
Tu M; Pfefferkorn JA; Guzman-Perez A; Filipski KJ
Pharm Pat Anal; 2012 Nov; 1(5):545-54. PubMed ID: 24236924
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutics based on tau/microtubule dynamics: WO2008084483.
Alonso Adel C; Corbo CP
Expert Opin Ther Pat; 2009 Sep; 19(9):1335-8. PubMed ID: 19555159
[TBL] [Abstract][Full Text] [Related]
17. Patent dispute threatens US Alzheimer's research.
Hayden EC
Nature; 2011 Apr; 472(7341):20. PubMed ID: 21475170
[No Abstract] [Full Text] [Related]
18. Natural Product Formulations for the Prevention and Treatment of Alzheimer's disease: A Patent Review.
Koynova R; Tenchov B
Recent Pat Drug Deliv Formul; 2018; 12(1):23-39. PubMed ID: 29219064
[TBL] [Abstract][Full Text] [Related]
19. Candida vaccines development from point view of US patent application.
Wang SJ
Hum Vaccin; 2011 Nov; 7(11):1165-71. PubMed ID: 22048114
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibitors: a patent review (2007 - 2011).
de los Ríos C
Expert Opin Ther Pat; 2012 Aug; 22(8):853-69. PubMed ID: 22764681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
